ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
동맥 협착 약물 시장 규모는 향후 수 년간 강력한 성장이 예상됩니다. 예측 기간 동안 예상되는 성장은 비만 및 당뇨병 유병률 증가, 최소 침습적 치료에 대한 수요 증가, 신흥 시장에서의 의료 접근성 증가, 의료비 지출 증가, 당뇨병 및 비만율의 지속적인 증가에 기인할 수 있습니다. 이 기간의 주요 동향으로는 맞춤형 의료 어프로치의 채택, 병용 요법의 확대, 진단 기술의 진보, 예방적 심장병학에 대한 인식 증가, 신규 드러그 딜리버리 시스템의 개발 등을 들 수 있습니다.
당뇨병과 비만의 유병률 상승이 향후 몇 년간의 동맥 협착 약물 시장의 성장을 견인할 것으로 예측됩니다. 당뇨병은 신체가 인슐린을 충분히 생산하지 못하거나 제대로 사용하지 못하는 만성 질환으로 혈당 수치가 상승하는 반면, 비만은 과도한 체지방으로 인해 다양한 건강 문제의 위험이 증가하는 것이 특징입니다. 당뇨병과 비만의 증가는 주로 앉아서 일하는 환경과 화면 기반 여가 활동과 관련된 규칙적인 신체 활동의 부족에 기인하며, 이는 체중 증가와 인슐린 저항성에 기여합니다. 당뇨병도 비만도 동맥에 플라크 축적을 촉진해, 심장 발작이나 뇌졸중의 리스크를 높이며, 동맥 협착 약물이 필수가 되고 있습니다. WHO는 2022년에 25억 명의 성인이 과체중이며, 8억 9,000만 명이 비만인으로 공존하고 있다고 보고했습니다.
고 콜레스테롤 혈증 치료의 개발은 혁신적인 치료제 개발을 통해 동맥 협착 약물 시장의 성장을 가속하고 있습니다. 시장의 주요 기업들은 고콜레스테롤 관리에 있어 충족되지 않은 의료 수요를 해결하기 위해 벰페도산을 포함한 치료법에 집중하고 있습니다. 벰페도산은 스타틴을 견디지 못하거나 추가적인 지질 강하 요법이 필요한 환자의 LDL 콜레스테롤 수치를 낮추기 위해 설계된 동급 최초의 약물입니다. 예를 들면, 2022년 5월, 인도의 제약회사 Zydus Lifesciences는 벤페도산을 함유하는 고콜레스테롤혈증의 경구 치료제 Bemdac를 발매했습니다. 간에서 콜레스테롤 합성을 표적으로 하는 새로운 유형의 약물을 제공하는 것으로, 스타틴계 약물에 흔히 나타나는 근육 관련 부작용을 최소화하면서 심혈관계의 결과를 개선하는 것을 목표로 하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 동맥 협착 약물 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 동맥 협착 약물 시장 : 성장률 분석
세계의 동맥 협착 약물 시장 실적: 규모와 성장, 2019-2024년
세계의 동맥 협착 약물 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 동맥 협착 약물 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 동맥 협착 약물 시장 : 약제유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
항혈소판제
항응고제
스타틴
베타 차단제
세계의 동맥 협착 약물 시장 : 작용기전별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
혈소판 응집 억제제
트롬빈 억제제
HMG-CoA 환원효소 억제제
베타 아드레날린 길항제
세계의 동맥 협착 약물 시장 : 투여 경로별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
경구
주사
경피
세계의 동맥 협착 약물 시장 : 환자 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
성인
고령자
소아
세계의 동맥 협착 약물 시장 : 항혈소판제유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
아스피린
클로피도그렐
치카그레롤
플러스그렐
지피리다 몰
세계의 동맥 협착 약물 시장 : 항응고제유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
와파린
헤파린
저분자량 헤파린
직접 경구 항응고제(DOAC)
세계의 동맥 협착 약물 시장 : 스타틴유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
아토르바스타틴
심바스타틴
로스바스타틴
프라바스타틴
로바스타틴
세계의 동맥 협착 약물 시장 : 베타 차단제유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
메토프롤롤
아테노롤
프로프라놀롤
카르베지롤
비소프롤롤
제7장 지역별/국가별 분석
세계의 동맥 협착 약물 시장 :지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 동맥 협착 약물 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
동맥 협착 약물 시장 : 경쟁 구도
동맥 협착 약물 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Johnson & Johnson Services Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bayer AG
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories
Novartis AG
Sanofi SA
GSK plc
Takeda Pharmaceutical Company Limited
Medtronic plc
Gilead Sciences Inc.
Amgen Inc.
Baxter International Inc.
Regeneron Pharmaceuticals Inc.
Lupin Limited
Alnylam Pharmaceuticals
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
동맥 협착 약물 시장 2029 : 새로운 기회를 제공하는 국가
동맥 협착 약물 시장 2029 : 새로운 기회를 제공하는 부문
동맥 협착 약물 시장 2029 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Artery stenosis drugs are medications designed to manage and treat the narrowing of arteries, a condition known as stenosis, which can lead to reduced blood flow and various health complications. These medications aim to alleviate symptoms, prevent further progression, and reduce the risk of severe events such as heart attacks or strokes.
The primary types of artery stenosis drugs include antiplatelet agents, anticoagulants, statins, and beta-blockers. Antiplatelet agents work by preventing platelets from clumping together to form blood clots. This category includes platelet aggregation inhibitors, thrombin inhibitors, HMG-CoA reductase inhibitors, and beta-adrenergic antagonists. These drugs can be administered through various routes, including oral, injectable, and transdermal forms, and are prescribed to different patient groups, including adults, the elderly, and pediatric patients.
The artery stenosis drug market research report is one of a series of new reports from The Business Research Company that provides artery stenosis drug market statistics, including the artery stenosis drug industry's global market size, regional shares, competitors with an artery stenosis drug market share, detailed artery stenosis drug market segments, market trends and opportunities, and any further data you may need to thrive in the artery stenosis drug industry. This artery stenosis drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The artery stenosis drug market size has grown strongly in recent years. It will grow from $2.47 billion in 2024 to $2.63 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth observed in the historical period can be attributed to several factors, including the rising incidence of cardiovascular diseases, an expanding geriatric population, increased awareness about arterial health, a greater use of telemedicine for patient monitoring, and advancements in healthcare infrastructure.
The artery stenosis drug market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth projected for the forecast period can be attributed to the rising prevalence of obesity and diabetes, a growing demand for minimally invasive treatments, increased healthcare access in emerging markets, rising healthcare expenditures, and the continued rise in diabetes and obesity rates. Key trends during this period include the adoption of personalized medicine approaches, a greater use of combination therapies, advancements in diagnostic techniques, a heightened focus on preventative cardiology, and the development of novel drug delivery systems.
The rising prevalence of diabetes and obesity is expected to drive the growth of the artery stenosis drug market in the coming years. Diabetes is a chronic condition where the body either produces insufficient insulin or cannot use it properly, leading to elevated blood sugar levels, while obesity is characterized by excessive body fat, increasing the risk of various health problems. The increase in diabetes and obesity is largely attributed to the lack of regular physical activity, which is linked to sedentary work environments and screen-based leisure activities, contributing to weight gain and insulin resistance. Both diabetes and obesity promote plaque buildup in arteries, heightening the risk of heart attacks and strokes, making artery stenosis drugs essential. For example, in March 2024, the World Health Organization (WHO) reported that in 2022, 2.5 billion adults were overweight, with 890 million living with obesity. As a result, the growing prevalence of diabetes and obesity is significantly contributing to the expansion of the artery stenosis drug market.
Advancements in the treatment of hypercholesterolemia are driving growth in the artery stenosis drug market through the development of innovative therapeutics. Major companies in the market are focusing on therapies including bempedoic acid to address unmet medical needs in managing high cholesterol. Bempedoic acid is a first-in-class drug designed to lower LDL cholesterol levels in patients who cannot tolerate statins or need additional lipid-lowering therapy. For example, in May 2022, Zydus Lifesciences Ltd., an India-based pharmaceutical company, launched Bemdac, an oral therapy for hypercholesterolemia containing bempedoic acid. This novel treatment option offers a new class of drug that targets cholesterol synthesis in the liver, aiming to improve cardiovascular outcomes while minimizing muscle-related side effects commonly associated with statins.
In January 2023, AstraZeneca plc, a UK-based pharmaceutical company, acquired CinCor Pharma Inc. for $1.8 billion. This acquisition enhances AstraZeneca's position in the cardiorenal pipeline by adding CinCor's drug, baxdrostat, an aldosterone synthase inhibitor (ASI) designed to lower blood pressure in treatment-resistant hypertension. The acquisition supports AstraZeneca's commitment to delivering innovative therapies that address complex diseases and improve patient outcomes. CinCor Pharma Inc. is a US-based biopharmaceutical company, specializing in developing novel treatments for cardiorenal diseases.
Major players in the artery stenosis drug market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Sanofi S.A., GSK plc, Takeda Pharmaceutical Company Limited, Medtronic plc, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Regeneron Pharmaceuticals Inc., Lupin Limited, and Alnylam Pharmaceuticals.
North America was the largest region in the artery stenosis drug market in 2024. The regions covered in artery stenosis drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the artery stenosis drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The artery stenosis drug market consists of sales of cholesterol-lowering drugs, calcium channel blockers, and hypertension medications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artery Stenosis Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artery stenosis drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artery stenosis drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artery stenosis drug market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Type: Antiplatelet Agents; Anticoagulants; Statins; Beta Blockers
2) By Mechanism Of Action: Platelet Aggregation Inhibitors; Thrombin Inhibitors; HMG-CoA Reductase Inhibitors; Beta-Adrenergic Antagonists
3) By Route Of Administration: Oral; Injectable; Transdermal
4) By Patient Type: Adults; Geriatric; Pediatric
Subsegments:
1) By Antiplatelet Agents: Aspirin; Clopidogrel; Ticagrelor; Prasugrel; Dipyridamole
2) By Anticoagulants: Warfarin; Heparin; Low Molecular Weight Heparins; Direct Oral Anticoagulants (DOACs)
3) By Statins: Atorvastatin; Simvastatin; Rosuvastatin; Pravastatin; Lovastatin
4) By Beta Blockers: Metoprolol; Atenolol; Propranolol; Carvedilol; Bisoprolol
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd; Merck & Co. Inc.; AbbVie Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Artery Stenosis Drug Market Characteristics
3. Artery Stenosis Drug Market Trends And Strategies
4. Artery Stenosis Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Artery Stenosis Drug Growth Analysis And Strategic Analysis Framework
5.1. Global Artery Stenosis Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Artery Stenosis Drug Market Growth Rate Analysis
5.4. Global Artery Stenosis Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Artery Stenosis Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Artery Stenosis Drug Total Addressable Market (TAM)
6. Artery Stenosis Drug Market Segmentation
6.1. Global Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antiplatelet Agents
Anticoagulants
Statins
Beta Blockers
6.2. Global Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Platelet Aggregation Inhibitors
Thrombin Inhibitors
HMG-CoA Reductase Inhibitors
Beta-Adrenergic Antagonists
6.3. Global Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Transdermal
6.4. Global Artery Stenosis Drug Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adults
Geriatric
Pediatric
6.5. Global Artery Stenosis Drug Market, Sub-Segmentation Of Antiplatelet Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aspirin
Clopidogrel
Ticagrelor
Prasugrel
Dipyridamole
6.6. Global Artery Stenosis Drug Market, Sub-Segmentation Of Anticoagulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Warfarin
Heparin
Low Molecular Weight Heparins
Direct Oral Anticoagulants (DOACs)
6.7. Global Artery Stenosis Drug Market, Sub-Segmentation Of Statins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atorvastatin
Simvastatin
Rosuvastatin
Pravastatin
Lovastatin
6.8. Global Artery Stenosis Drug Market, Sub-Segmentation Of Beta Blockers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metoprolol
Atenolol
Propranolol
Carvedilol
Bisoprolol
7. Artery Stenosis Drug Market Regional And Country Analysis
7.1. Global Artery Stenosis Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Artery Stenosis Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Artery Stenosis Drug Market
8.1. Asia-Pacific Artery Stenosis Drug Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Artery Stenosis Drug Market
9.1. China Artery Stenosis Drug Market Overview
9.2. China Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Artery Stenosis Drug Market
10.1. India Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Artery Stenosis Drug Market
11.1. Japan Artery Stenosis Drug Market Overview
11.2. Japan Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Artery Stenosis Drug Market
12.1. Australia Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Artery Stenosis Drug Market
13.1. Indonesia Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Artery Stenosis Drug Market
14.1. South Korea Artery Stenosis Drug Market Overview
14.2. South Korea Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Artery Stenosis Drug Market
15.1. Western Europe Artery Stenosis Drug Market Overview
15.2. Western Europe Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Artery Stenosis Drug Market
16.1. UK Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Artery Stenosis Drug Market
17.1. Germany Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Artery Stenosis Drug Market
18.1. France Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Artery Stenosis Drug Market
19.1. Italy Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Artery Stenosis Drug Market
20.1. Spain Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Artery Stenosis Drug Market
21.1. Eastern Europe Artery Stenosis Drug Market Overview
21.2. Eastern Europe Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Artery Stenosis Drug Market
22.1. Russia Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Artery Stenosis Drug Market
23.1. North America Artery Stenosis Drug Market Overview
23.2. North America Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Artery Stenosis Drug Market
24.1. USA Artery Stenosis Drug Market Overview
24.2. USA Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Artery Stenosis Drug Market
25.1. Canada Artery Stenosis Drug Market Overview
25.2. Canada Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Artery Stenosis Drug Market
26.1. South America Artery Stenosis Drug Market Overview
26.2. South America Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Artery Stenosis Drug Market
27.1. Brazil Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Artery Stenosis Drug Market
28.1. Middle East Artery Stenosis Drug Market Overview
28.2. Middle East Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Artery Stenosis Drug Market
29.1. Africa Artery Stenosis Drug Market Overview
29.2. Africa Artery Stenosis Drug Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Artery Stenosis Drug Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Artery Stenosis Drug Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Artery Stenosis Drug Market Competitive Landscape And Company Profiles
30.1. Artery Stenosis Drug Market Competitive Landscape
30.2. Artery Stenosis Drug Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Artery Stenosis Drug Market Other Major And Innovative Companies
31.1. Bayer AG
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca PLC
31.4. Abbott Laboratories
31.5. Novartis AG
31.6. Sanofi S.A.
31.7. GSK plc
31.8. Takeda Pharmaceutical Company Limited
31.9. Medtronic plc
31.10. Gilead Sciences Inc.
31.11. Amgen Inc.
31.12. Baxter International Inc.
31.13. Regeneron Pharmaceuticals Inc.
31.14. Lupin Limited
31.15. Alnylam Pharmaceuticals
32. Global Artery Stenosis Drug Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Artery Stenosis Drug Market
34. Recent Developments In The Artery Stenosis Drug Market
35. Artery Stenosis Drug Market High Potential Countries, Segments and Strategies
35.1 Artery Stenosis Drug Market In 2029 - Countries Offering Most New Opportunities
35.2 Artery Stenosis Drug Market In 2029 - Segments Offering Most New Opportunities
35.3 Artery Stenosis Drug Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
